The European Union has released draft revisions to Chapter 4 of the Good Manufacturing Practice (GMP) guideline on documentation, part of EudraLex Volume 4 for medicinal products.
Misunderstanding the difference between deviation and nonconformance can lead to costly quality mistakes in pharma, biotech, and medical device industries.
Some parts of ISO 13485 may not apply to all medical device manufacturers, but knowing which clauses can be left out—and why—is essential to building a compliant and effective quality management system.
Quality Management Maturity (QMM) and Operational Excellence (OpEx) are crucial frameworks pharmaceutical and medical device leaders must adopt to enhance product safety, comply with regulations, and improve overall efficiency.
Gustavo Oliveira, a trilingual professional specializing in pharmaceutical quality assurance, discusses the challenges faced when suppliers are unprepared for GxP audits,
The CAPA (Corrective and Preventive Action) process for medical devices is at times threatened by common mistakes, but there are strategies to avoid them.
A blog post by Quality Systems Now shows that a Clinical Quality Management System (CQMS) plays a crucial role in ensuring the safety and success of clinical trials.
When launching Greenfield projects in the pharmaceutical or medical device industries, businesses often face the decision between Good Manufacturing Practice (GMP) licensing and ISO 13485 accreditation.
Identifying and controlling Critical Process Parameters (CPPs) is essential to maintaining quality and consistency in medical and pharmaceutical industries, according to Quality Systems Now's blog post.
Dr. Murugan Kandasamy, Managing Director & CEO at DQS India, Head - Medical Global Support Center, has published a new blog post about Classification of Medical Devices under EU MDR. The most important issues he discusses are: